Patent · US Active

Compounds and methods of treating retinal degeneration

US11744826B2 · kind B2 · utility

1Cited by

2References

6Claims

0Family size

Assignees

CASE WESTERN RESERVE UNIVERSITY · US
University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Krzysztof Palczewski · Bay Village, US
Yuanyuan Chen · Wenzhou, CN

Key dates

Filing date	Dec 7, 2021
Grant date	Sep 5, 2023
Priority date	—
Expiry date	Dec 7, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating retinal degeneration in a subject includes administering to the subject a therapeutically effective amount of a compound of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.